North America Pharmaceutical Solvent Market, By Product (Alcohol, Amine, Esters, Ethers, Aromatic Hydrocarbons, Chlorinated Solvents, Ketones, And Others), Applications (Pharmaceutical, Research Laboratories, Chemical, And Others), Country (U.S., Canada, and Mexico) Market Trends and Forecast to 2028.
Market Analysis and Insights: North America Pharmaceutical Solvent Market
North America pharmaceutical solvent market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the market is growing at a CAGR of 4.6% in the forecast period of 2021 to 2028 and expected to reach USD 2,271,558.55 thousand by 2028.
Pharmaceutical solvents refer to chemical compounds, which are majorly utilized in the manufacturing of drugs in the pharmaceutical industry. These solvents are used in dissolving other products and components finding its usage as a manufacturing block by providing the molecules required in the production of drugs and pharmaceuticals. These solvents are also utilized in the extraction and purification process. Most of the pharmaceutical solvents cannot be removed completely from the final drugs. It is, however, desired that a pharmaceutical solvent should not change properties of either of the chemicals involved in the reaction.
These alcoholic solvents are utilized in numerous major pharmaceutical drugs such as glycol, isopropanol, and ethanol and growth of pharmaceutical and healthcare sector are the major factors driving the market growth. Furthermore, high production costs and complex manufacturing process act as a restraint for the growth of the market. On the other hand, growing research and development activities and development of new drug manufacturing methods and technologies act as an opportunity for the market. However, rise in concerns regarding the toxicity of solvents might further create challenges for the market growth.
The North America pharmaceutical solvent market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Global Pharmaceutical Solvent Market scenario, contact Data Bridge Market Research for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
North America Pharmaceutical Solvent Market Scope and Market Size
North America pharmaceutical solvent market is segmented into two notable segments, which are based on product and application. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product, the North America pharmaceutical solvent market is segmented into alcohol, amine, esters, ethers, aromatic hydrocarbons, chlorinated solvents, ketones, and others. In 2021, the alcohol segment is expected to dominate the North America pharmaceutical solvent market as the alcoholic solvent dissolves the drugs without altering the composition and addition possesses several concentration-dependent pharmacological actions including sedative, carminative, cooling, antipyretic, rubefacient, cleansing, and antiseptic properties.
- On the basis of application, the North America pharmaceutical solvent market is segmented into Pharmaceutical, Research Laboratories, Chemical, and Others. In 2021, the pharmaceutical segment is expected to dominate the market as the alcoholic solvent has extensive use in the region as topical disinfectant and sanitizer.
Pharmaceutical Solvent Market Country Level Analysis
North America market is analysed and market size information is provided by product and application. The countries covered in the North America pharmaceutical solvent market report are the U.S., Canada, and Mexico. North America is dominating the market due to growing pharmaceutical and healthcare sector in the region.
Pharmaceutical Solvent Market, By Application
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growth in Medical Research and Development is Boosting the North America Pharmaceutical Solvent Market Growth
North America pharmaceutical solvent market also provides you with detailed market analysis for every country growth in installed base of different kind of products for the market, impact of technology using life line curves and changes in infant formula regulatory scenarios and their impact on the market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Pharmaceutical Solvent Market Share Analysis
North America pharmaceutical solvent market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to the North America pharmaceutical solvent market.
Major players engaged in the global pharmaceutical solvent market are Dupont, Mitsui Chemicals, DOW, Brenntag SE, Merck KGaA, Royal Dutch Shell Plc, BASF SE, Exxon Mobil Corporation, Clariant, Eastman Chemical Company, LyondellBasell Industries Holdings B.V., Olin Corporation, SK geo centric Co., Ltd., Avantor, Inc., among others
For instance,
- In July 2021, DuPont completed the acquisition of Laird Performance Materials, a world leader in high-performance electromagnetic shielding and thermal management solutions. This will help the company to expand its customer base and global scale to increase speed to the market.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRODUCT LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 DBMR MARKET CHALLENGE MATRIX
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 RAW MATERIAL OUTLOOK
4.2 ADOPTION SCENARIO AMONG BUYERS
4.3 VALUE CHAIN ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWTH IN PHARMACEUTICAL, AND HEALTHCARE SECTOR ACROSS THE GLOBE
5.1.2 RISE IN PRODUCTION OF INNOVATIVE GENERIC DRUGS, PARTICULARLY IN EMERGING ECONOMIES
5.1.3 INCREASE IN DEMAND FOR ALCOHOL SOLVENTS FOR MANUFACTURING OF VARIOUS DRUGS
5.2 RESTRAINTS
5.2.1 HIGH PRODUCTION COSTS, AND COMPLEX MANUFACTURING PROCESS
5.2.2 STRINGENT REGULATIONS REGARDING THE USE OF CERTAIN CONVENTIONAL SOLVENTS
5.3 OPPORTUNITIES
5.3.1 GROWTH IN RESEARCH AND DEVELOPMENT ACTIVITIES
5.3.2 DEVELOPMENT OF NEW DRUG MANUFACTURING METHODS AND TECHNOLOGIES
5.3.3 RISE IN ADOPTION OF GREEN MATERIALS AND CHEMICALS FOR DRUG MANUFACTURING
5.4 CHALLENGES
5.4.1 RISE IN CONCERNS REGARDING THE TOXICITY OF SOLVENTS
5.4.2 OCCURRENCES OF FATALITIES IN THE PHARMACEUTICAL SOLVENT MANUFACTURING COMPANIES
6 ANALYSIS ON IMPACT OF COVID-19 ON THE MARKET
6.1 AFTERMATH OF COVID-19 AND THE GOVERNMENT INITIATIVE TO BOOST THE MARKET
6.2 STRATEGIC DECISIONS OF MANUFACTURERS AFTER COVID-19 TO GET COMPETITIVE MARKET SHARE
6.3 IMPACT ON PRICE
6.4 IMPACT ON DEMAND
6.5 IMPACT ON SUPPLY CHAIN
6.6 CONCLUSION
7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 ALCOHOL
7.2.1 METHANOL
7.2.2 ETHANOL
7.2.3 1-BUTANOL
7.2.4 2-BUTANOL
7.2.5 2-METHOXYETHANOL
7.2.6 3-METHYL-1-PROPANOL
7.2.7 2-METHYL-1-PROPANOL
7.2.8 1-PENTANOL
7.2.9 1-PROPANOL
7.2.10 2-PROPANOL (ISOPROPYL ALCOHOL)
7.2.11 OTHERS
7.3 AROMATIC HYDROCARBONS
7.3.1 TOLUENE
7.3.2 XYLENE
7.3.3 ETHYLBENZENE
7.3.4 OTHERS
7.4 KETONES
7.4.1 ACETONE
7.4.2 CYCLOHEXANONE
7.4.3 METHYL ETHER KETONE
7.4.4 METHYL ETHYL KETONE
7.4.5 METHYL ISOBUTYL KETONE
7.4.6 OTHERS
7.5 ETHERS
7.5.1 DIETHYL ETHER
7.5.2 METHOXYETHANE
7.5.3 TETRAHYDROFURAN
7.5.4 METHYL TERT-BUTYL ETHER
7.5.5 DI-N-PROPYL ETHER
7.5.6 OTHERS
7.6 AMINE
7.6.1 MONOETHANOLAMINE (MEA)
7.6.2 DIETHANOLAMINE (DEA)
7.6.3 METHYLDIETHANOLAMINE (MDEA)
7.6.4 OTHERS
7.7 ESTERS
7.7.1 ACETYL ACETATE
7.7.2 ETHYL ACETATE
7.7.3 BUTYL ACETATE
7.7.4 OTHERS
7.8 CHLORINATED SOLVENTS
7.8.1 TRICHLOROETHYLENE (TCE)
7.8.2 PERCHLOROETHYLENE (PCE)
7.8.3 1,1,1-TRICHLOROETHANE (TCA)
7.8.4 OTHERS
7.9 OTHERS
8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICAL
8.3 RESEARCH LABORATORIES
8.4 CHEMICAL
8.5 OTHERS
9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
9.1 NORTH AMERICA
9.1.1 U.S.
9.1.2 CANADA
9.1.3 MEXICO
10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.2 MERGERS & ACQUISITIONS
10.3 EXPANSION
10.4 NEW PRODUCT DEVELOPMENT
10.5 PARTNERSHIP
10.6 AGREEMENTS
10.7 AWARD AND CERTIFICATION
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 ROYAL DUTCH SHELL PLC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUS ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 BASF SE
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUS ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MERCK KGAA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 EXXON MOBIL CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BRENNTAG SE
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENT
12.6 DUPONT
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUS ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 MITSUI CHEMICALS
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 DOW
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUS ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUS ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.1 CLARIANT AG
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 AVANTOR, INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENT
12.12 EASTMAN CHEMICAL COMPANY
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUS ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENT
12.13 OLIN CORPORATION
12.13.1 COMPANY SNAPSHOT
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENT
12.14 SK GEO CENTRIC CO., LTD. (A SUBSIDIARY OF SK NORTH AMERICA CHEMICAL)
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 INNOVATORS OF GENERIC DRUGS
TABLE 2 DRUGS DEVELOPMENT IN THE YEAR 2021
TABLE 3 CLASSES OF SOLVENTS AND THEIR HARMFUL EFFECTS
TABLE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 6 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 7 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 8 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 9 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 10 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 11 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 12 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 13 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 14 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 15 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 16 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 17 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 18 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 19 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS )
TABLE 20 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 21 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 22 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 23 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 24 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 25 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 26 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 27 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 28 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 29 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 30 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 31 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 32 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 33 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 34 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 35 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 36 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 37 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 38 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 39 NORTH AMERICA PHARMACEUTICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 40 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 41 NORTH AMERICA RESEARCH LABORATORIES IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 42 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 43 NORTH AMERICA CHEMICAL IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 44 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 45 NORTH AMERICA OTHERS IN PHARMACEUTICAL SOLVENT MARKET, BY REGION, 2019-2028 (THOUSAND TONS)
TABLE 46 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)
TABLE 47 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2019-2028 (THOUSAND TONS)
TABLE 48 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 49 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 50 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 51 NORTH AMERICA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 52 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 53 NORTH AMERICA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 54 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 55 NORTH AMERICA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 56 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 57 NORTH AMERICA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 58 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 59 NORTH AMERICA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 60 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 61 NORTH AMERICA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 62 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 63 NORTH AMERICA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 64 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 65 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 66 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 67 U.S. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 68 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 69 U.S. ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 70 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 71 U.S. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 72 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 73 U.S. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 74 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 75 U.S. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 76 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 77 U.S. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 78 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 79 U.S. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 80 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 81 U.S. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 82 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 83 U.S. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 84 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 85 CANADA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 86 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 87 CANADA ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 88 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 89 CANADA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 90 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 91 CANADA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 92 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 93 CANADA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 94 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 95 CANADA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 96 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 97 CANADA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 98 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 99 CANADA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 100 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 101 CANADA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
TABLE 102 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 103 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 104 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 105 MEXICO ALCOHOL IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 106 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 107 MEXICO AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 108 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 109 MEXICO KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 110 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 111 MEXICO ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 112 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 113 MEXICO AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 114 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 115 MEXICO ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 116 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 117 MEXICO CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2019-2028 (THOUSAND TONS)
TABLE 118 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 119 MEXICO PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2019-2028 (THOUSAND TONS)
List of Figure
FIGURE 1 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: PRODUCT LIFELINE CURVE
FIGURE 7 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: DBMR POSITION GRID
FIGURE 10 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 12 NORTH AMERICA PHARMACEUTICAL SOLVENT: THE MARKET CHALLENGE MATRIX
FIGURE 13 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 14 ASIA-PACIFIC REGION IS EXPECTED TO DOMINATE THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET, AND TO GROW WITH THE HIGHEST CAGR FROM 2021 TO 2028
FIGURE 15 THE GROWING PHARMACEUTICAL AND HEALTHCARE SECTOR ACROSS THE GLOBE IS DRIVING THE GROWTH OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 ALCOHOL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET IN 2021 & 2028
FIGURE 17 VALUE CHAIN OF PHARMACEUTICAL SOLVENT
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET
FIGURE 19 WORLDWIDE GDP PER CAPITA INCOME
FIGURE 20 NEW DRUGS APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (2010-2020)
FIGURE 21 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2020
FIGURE 22 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2020
FIGURE 23 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: SNAPSHOT (2020)
FIGURE 24 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020)
FIGURE 25 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 26 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 27 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT (2021-2028)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL SOLVENT MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
